A discussion on advances in biomarker research
All Things Grants. Q&A with a Grant Reviewer and two Grant Writers – Tips & Tricks for Success.
“An advice I would give to a beginner grant writer is to take the reviewer by hand, take him one step at the time in a logical fashion through that…
Digital Spatial Profiling Q&A Services and Core Labs
Excellence, Cooperation, and Passion Come Together to Serve the Scientific Community. Q&A with Dr. Peter O’Toole, Director of the Bioscience Technology Facility, University of York.
Dr. Peter O’Toole, Ph.D., is the director of the Bioscience Technology Facility at the University of York in England, where he established and still leads the Imaging and Cytometry Laboratory, one of the…
Oncology Panels Q&A
Statistically Significant Results without the Headache. Q&A with Sarah Church, PhD, Senior Scientist at NanoString.
Talking to Sarah, whether during social gatherings or within the office walls, is always a pleasure. Dr. Church is a Senior Scientist at NanoString, and one of the warmest people…
Immunity Infectious Disease Publication Watch
COVID-19 Pathogenesis Steps Out of the Shadows
“Analysis of pulmonary vessels showed that widespread thrombosis with microangiopathy ─ a severe condition wherein small blood clots are formed within the tiniest of blood vessels ─ was 9x more…
Panels Q&A Services and Core Labs
Spotlight on a CRO: Interview with the Team of Scientists behind NeoGenomics Pharma Services.
NeoGenomics is a cancer diagnostics and pharma services company serving pharmaceutical companies and academic centers. They specialize in diagnostic, prognostic and predictive testing using the most innovative technologies. The company…
Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.
Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a…